Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Emilio Poggio, MD

216.444.6771

Emilio Poggio, MD
Department: Nephrology and Hypertension
Location: Cleveland Clinic Main Campus
Mail Code Q7
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6771
DeskDesk:216.444.5383
WorkFax:216.444.9378
Emilio Poggio, MD
Department: Immunology
Location: Cleveland Clinic Main Campus
Mail Code Q7
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5383
WorkFax:216.444.9378
Emilio Poggio, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code Q7
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5383
WorkFax:216.444.9378
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Emilio D. Poggio, MD, FASN, is an Associate Staff in the Department of Nephrology and Hypertension of the Glickman Urological and Kidney Institute at Cleveland Clinic. He also has joint appointments in the Transplant Center, Cleveland Clinic, and the Department of Immunology at Lerner Research Institute.

Dr. Poggio is board-certified in internal medicine and in nephrology and hypertension. His clinical practice focuses on the care of subjects with kidney disease, specifically kidney and pancreas transplant candidates and recipients, and those with kidney disease following nonrenal organ transplantation.

Dr. Poggio has several major areas of clinical and translational research and has published and lectured about these topics:

  • Assessment of kidney function (glomerular filtration rate) in health and in disease
  • Living donor kidney factors that relate to outcomes for transplant recipients and the development of tools to risk-stratify patients based on pretransplantation data
  • Development of novel cellular immune-monitoring techniques in the setting of organ transplantation.  

Dr. Poggio holds an NIH grant through the NIAID until 2012 to study immune-monitoring tools in kidney transplant candidates and how these novel noninvasive approaches can help to predict outcomes and individualize patient care.

Professional Highlights

  • Medical Director, Pancreas Transplant Program
  • Director, Renal Function Laboratory
  • Director, Clinical Research of Kidney Transplant Program

Education & Fellowships

Fellowship - Cleveland Clinic
Research Nephrology & Hypertension
Cleveland, OH USA
2003
Fellowship - Cleveland Clinic
Nephrology & Hypertension
Cleveland, OH USA
2003
Fellowship - Fundacion Favaloro
Renal Transplant
Buenos Aires Argentina
2001
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1999
Internship - Boston Medical Center
Rotational
Boston, MA USA
1996
Medical School - Universidad del Salvador
Buenos Aires Argentina
1993

Certifications

  • Internal Medicine- Nephrology

Specialty Interests

Kidney disease in solid organ transplantation, evaluation of renal function, kidney and pancreas transplantation, Chronic Kidney Disease, Kidney Transplantation, pancreas transplantation

Memberships

  • American Society of Transplantation
  • American Society of Nephrology
  • The Transplantation Society

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/29/2014, Dr. Poggio has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Poggio receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Novartis Pharmaceuticals Corporation
  • Sanofi S.A.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Spanish